Chronic non-atrophic gastritis with erosion
Conditions
Interventions
The treatment group:Shihu Yiwei Fang
The control group:Rebamipide Tablets
Sponsors
Affiliated Hospital of Changchun University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Meeting the Western diagnostic criteria for chronic non-atrophic gastritis with erosion. (2) It meets the standard of TCM diagnosis of Weiyin Buzu syndrome. (3) Age 18-70 (including 18 and 70).
Exclusion criteria
Exclusion criteria: (1) Patients with gastric and duodenal ulcers, gastritis with active bleeding, atrophic gastritis, gastric mucosal dysplasia or suspected malignant change by pathological diagnosis. Patients with gastrointestinal bleeding or after gastric surgery. (2) Combined with cardiovascular, cerebrovascular, liver, kidney, endocrine, hematopoietic system and other serious primary diseases, as well as other diseases other than chronic non-atrophic gastritis that affect the experimental drug observation. (3) Taking proton pump inhibitors, bismuth, antibiotics and other drugs that affect the efficacy observation within one month. (4) Helicobacter pylori infection. (5) Women who are pregnant or recently preparing to become pregnant, breast-feeding women. (6) Allergic constitution or components of the drug. (7) Participate in other clinical trials within 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement rate of gastric mucosal erosion under gastroscopy; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome integration;Symptoms integral;Cure rate of gastroscopic erosion of gastric mucosa;Quality of life score;Improvement rate of edema, erythema and bleeding under gastroscope; | — |
Countries
China
Contacts
Public ContactXiongzhuang
Outcome results
None listed